17 DEC 2025 | By Dr Gaurav Kharya

Rare diseases in India: Are we failing children who could be cured in time?

Despite advances in transplant capacity and policy frameworks, early detection, affordable treatment, and coordinated rare-disease care remain urgent national needs

01 AUG 2025 | By Dr Gaurav Kharya

India's cancer battle: Why positivity and early diagnosis are key to higher survival rates

Positivity in cancer treatment, especially for children, is highlighted as a profoundly potent tool that enhances healing and outcomes, going beyond medical protocols

20 JUN 2025 | By Dr Gaurav Kharya

World Sickle Cell Day | What India needs to do to eliminate this genetic blood disorder by 2047

The National Sickle Cell Elimination Mission has made a promising start, but the road to 2047 will require public-private collaboration and consistent efforts to achieve its grand vision

16 JUN 2025 | By Dr Gaurav Kharya

Stem cell transplantation: Why India needs more donors

Every year in India, thousands of children are born with blood disorders like thalassemia major and sickle cell anemia—conditions that condemn them to a life of regular blood transfusions, chronic pain, social stigma, and premature death unless they receive a curative treatment: a stem cell transplant.

21 SEP 2024 | By Dr Gaurav Kharya

OPINION | CAR T-cell therapy is proving to be promising in the treatment of solid tumours

Chimeric Antigen Receptor T-cell (CAR T-cell) therapy has been used and is fast becoming a treatment of choice for patients suffering from blood cancers like leukemia and lymphoma.

19 JUN 2024 | By Dr Gaurav Kharya

It is time to prioritise Sickle Cell Disease care in India

Sickle cell disease (SCD) is a severe hereditary blood disorder that poses a significant public health challenge in India, particularly in regions with high malaria rates, known as the "sickle belt," which extends from West Bengal, Orissa, Jharkhand, Madhya Pradesh, Chhattisgarh, and Bihar to Maharashtra and Gujarat.

10 JUL 2024 | By Dr Gaurav Kharya

How cell and gene therapies revolutionising cancer care in India

Our body is made up of cells, and whatever happens to it—good or bad—happens at a cellular level. Cancer, for example, occurs due to a small change in the cell that prompts it to proliferate abnormally. Also, cancer spreads in the body because the immune cells lose their ability to identify the danger cancer cells pose and stop them from growing. We treat cancer by surgically removing the cancer cells from the body or by giving drugs that kill the malignant cells.

17 AUG 2024 | By Dr Gaurav Kharya

Rewriting our DNA: The potential of gene editing for blood disorders and beyond

Gene editing, particularly with CRISPR-Cas9 technology, has shown potential to revolutionise medicine by offering cures for a range of genetic disorders, especially blood disorders such as sickle-cell anaemia.

03 FEB 2016 | By Gunjan Sharma

Young and Thriving

Navdeep Kaur is chirpy, her eyes bright as she watches a movie on her tablet during the last cycle of chemotherapy at BLK Hospital in Delhi. So contagious is her cheerfulness that her grandmother Gurmail Kaur, who is sitting beside her, is hardly nervous.